NEO - Company ID 0001077183
The table below shows NEOGENOMICS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $159.62M | $367.01M | $342.49M | $263.18M | $316.83M | $228.71M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $159.24M | $150.54M | $131.23M | $119.71M | $112.13M | $106.84M |
| Inventory | $28.57M | $26.75M | $24.16M | $24.28M | $23.39M | $29.53M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $376.29M |
| $596.02M |
| $596.81M |
| $605.29M |
| $681.51M |
| $448.73M |
| Property, plant & equipment | $84.83M | $94.10M | $92.01M | $102.50M | $109.47M | $85.87M |
| Goodwill | $524.34M | $522.77M | $522.77M | $522.77M | $527.12M | $211.08M |
| Total assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988.33M |
| Accounts payable | $23.09M | $21.61M | $20.33M | $20.51M | $17.92M | $24.96M |
| Total current liabilities | $88.30M | $301.24M | $96.30M | $89.93M | $87.23M | $73.18M |
| Long-term debt | $341.86M | $340.33M | - | - | - | - |
| Total liabilities | $523.27M | $735.70M | $739.69M | $742.01M | $761.50M | $294.04M |
| Retained earnings | -$433.81M | -$325.78M | -$247.06M | -$159.09M | -$14.84M | -$7.18M |
| Total equity | $836.56M | $902.34M | $941.54M | $998.02M | $1.11B | $694.29M |